Overview
Lobbying Costs
100,000€ - 199,999€
Financial year: Jul 2023 - Jun 2024
Lobbyists (Full time equivalent)
0.5 Fte (2)
Lobbyists with EP accreditation
1
High-level Commission meetings
3
Lobbying Costs over the years
-
Info
ResMed (RMD)
EU Transparency Register
209143033529-94 First registered on 21 Dec 2018
Goals / Remit
ResMed (NYSE: RMD, ASX: RMD) manufactures digital health technologies and cloud-connected medical devices transform care for people with sleep apnoea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries.
Main EU files targeted
• Implementation of Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices (MDR)
• Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data (GDPR)
• European Health Data Space proposal COM(2022) 197 final
• European Strategy for Data COM(2020) 66 final
• Regulation (EU) 2024/1689 of the European Parliament and of the Council of 13 June 2024 laying down harmonised rules on artificial intelligence (AI Act)
• EU Green Deal
• Regulation (EU) 2023/2854 of the European Parliament and of the Council of 13 December 2023 on harmonised rules on fair access to and use of data and amending Regulation (EU) 2017/2394 and Directive (EU) 2020/1828 (Data Act)Address
Head Office
9001 Spectrum Center Blvd
San Diego 92123
UNITED STATESEU Office
Bolwerklaan 21 Box 8
Brussels 1210
BELGIUMWebsite
-
People
Total lobbyists declared
2
Employment time Lobbyists 25% 2 Lobbyists (Full time equivalent)
0.5
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
1 accreditations were / are live (in bold) for the selected state of 21 Nov 2024
Name Start date End Date Justyna VANDENBOSCH 08 Oct 2024 08 Oct 2025 Justyna VANDENBOSCH 25 Jan 2024 04 Oct 2024 Francesca RISSO 24 Jan 2024 04 Oct 2024 Justyna VANDENBOSCH 25 Jan 2023 25 Jan 2024 Francesca RISSO 22 Oct 2022 21 Oct 2023 Complementary Information
None declared
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Companies & groups
-
Networking
Affiliation
MedTech Europe: https://www.medtecheurope.org/
DIGITALEUROPE: https://www.digitaleurope.org/
European Business Summit https://ebsummits.eu/
EGN https://be.egn.com/Member organisations
None declared
-
Financial Data
Interests represented
Promotes their own interests or the collective interests of their members
Closed financial year
Jul 2023 - Jun 2024
Lobbying costs for closed financial year
100,000€ - 199,999€
Major contributions in closed year
None declared
Intermediaries for closed year
Name Amount fti consulting belgium 25,000€ - 49,999€ Intermediaries for current year
Name fti consulting Closed year Costs
100,000€ - 199,999€
Other financial info
None declared
-
EU Structures
Groups (European Commission)
None declared
Groups (European Parliament)
N/A
Communication activities
- Engaging with European Commission officials including Commissioners, cabinet members and services in DGs such as DG Grow, DG Connect and DG Sante; with MEPS and secretariats on committees such as IMCO, SANT, ENVI and ITRE; and with officials in the Working Party on Pharmaceuticals and Medical Devices in the Council of Ministers and Permanent Representations
- Attending public hearings and events hosted in the EU institutions related to healthcare and digital policyOther activities
None declared
Meetings
Meetings
3 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.
-
Date 10 Oct 2024 Location Brussels Subject EB Summit Cabinet Cabinet of President Ursula von der Leyen Attending - Peter van Kemseke (Cabinet member)
Other Lobbyists -
Date 25 Mar 2020 Location Videoconference Subject Videoconference with CEOs on COVID-19 Cabinet Cabinet of President Ursula von der Leyen Portfolio President Attending - Ursula von der Leyen (President)
Other Lobbyists -
Date 25 Mar 2020 Location Videoconference Subject Videoconference with CEOs on COVID-19 Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Thierry Breton (Commissioner)
Other Lobbyists